President Donald Trump on Sunday once again touted the potential life-saving benefits of treating coronavirus patients with hydroxychloroquine, a powerful anti-malaria drug, despite a dearth of medical professionals or clinical evidence supporting his claims.
It just so happens that one of the largest manufacturers of the drug, Novartis, previously paid Trump’s now-incarcerated former personal attorney Michael Cohen more than $1 million for healthcare policy insight following Trump’s election in 2016...